doi: 10.3389/fonc.2015.00183 24 PalmieriGColombinoMCasulaMMancaAMandalMCossuA
Retrieved March 10, 2026, from After adding coverage of GLP-1s for weight loss August 1, 2024, North Carolina Medicaid reversed course to end coverage effective October 1, 2025, due to North Carolina Department of Health and Human Services (DHHS) anticipated shortfalls in state funding prompted by budget disagreements in the North Carolina General Assembly
Lin L, Wen J, Lin B, Bhandari A, Zheng D, Kong L, et al
However, these cardiovascular applications require particularly careful consideration given the potential risks associated with promoting angiogenesis in patients who may have undiagnosed malignancies or other conditions where angiogenesis promotion could be detrimental
Slower dose titration The standard dose escalation schedule for GLP-1 medications moves patients up to the next dose every 4 weeks
This depends entirely on your current medication regimen